Stocksigma LogoStocksigma Logo

Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion

Anuh Pharma reported Q2 ended 30th Sep'26 revenue from operations of ₹18,524.14 lakhs, marginally lower YoY versus ₹18,588.27 lakhs and down 4.4% QoQ

Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion

Anuh Pharma Ltd · Financial Result · 30 Oct 2026, 10:30 pm

Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion Anuh Pharma reported Q2 ended 30th Sep'26 revenue from operations of ₹18,524.14 lakhs, marginally lower YoY versus ₹18,588.27 lakhs and down 4.4% QoQ. Despite flat top-line growth, net profit surged 47.3% YoY to ₹1,121.31 lakhs (QoQ: ₹1,142.49 lakhs), driven by operating efficiencies. EBITDA rose 36.5% YoY to ₹1,755.13 lakhs with EBITDA margins expanding 255 bps YoY to 9.47%. Adjusted EBITDA reached ₹1,873.67 lakhs (10.11% margin). EPS stood at ₹1.12. For H1 ended 30th Sep'26, PAT climbed 42.3% YoY to ₹2,263.80 lakhs.

Original exchange filing (PDF)

More announcements from Anuh Pharma Ltd

All Anuh Pharma Ltd announcements